Advanta has developed a new diagnostic test for the virus that causes COVID-19 (referred to as SARS-CoV-2). This test uses NGS to detect the virus quickly and with high sensitivity.

By using a molecular syndromic approach and a broad test menu, we can better detect and identify the infectious agent with just one easy diagnostic test. Advanta's infectious disease testing increases the probability of identifying a pathogen in patients with symptoms of an infectious disease and increases the capability of detection of co-infections.

Since we are a full-service anatomic pathology lab specializing in podiatric medicine, we issue reports on a variety of specimens from the lower limbs including but not limited to: Bone, cysts, tumors, skin, soft tissue, nails, and foreign bodies.

Molecular diagnostics is a broad term describing a class of diagnostic tests that assess a person's health literally at a molecular level, detecting and measuring specific genetic sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) or the proteins they express.

Toxicology screens are used to identify substances affecting a patient and to guide the clinician to predict future toxic effects, to confirm the differential diagnosis or to guide therapy.

The Women's Health menu was designed to serve the OB/GYN practitioner. Advanta's menu includes all relevant tests in women's health, including conventional Pap tests to molecular diagnostic testing for infectious diseases.